Platelets in atherothrombosis

David A Vorchheimer1, Richard Becker

  • 1Zena and Michael Wiener Cardiovascular Institute, Mount Sinai School of Medicine, Box 1030, 1 Gustave Levy Pl, New York, NY 10029, USA. david.vorcheimer@msnyuhealth.org

Mayo Clinic Proceedings
|January 28, 2006
PubMed

Insights

Platelets are central to atherothrombosis, mediating both coagulation and inflammation. Antiplatelet agents are key in preventing and treating cardiovascular disease events like stroke and heart attack.

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Pathology

Background:

  • Atherosclerosis is a systemic arterial disease leading to plaque disruption, thrombus formation, and occlusion.
  • This atherothrombotic process underlies critical cardiovascular events such as myocardial infarction and stroke.
  • Platelets, once considered passive, are now recognized as active mediators of coagulation and inflammation.

Purpose of the Study:

  • To review the critical role of platelets in atherothrombosis.
  • To discuss the involvement of platelets in coagulation and inflammation.
  • To examine the efficacy of antiplatelet therapies in cardiovascular disease.

Main Methods:

  • Literature review of atherosclerosis and platelet function.
  • Analysis of platelet's role in atherothrombotic events.
  • Evaluation of antiplatelet agent efficacy.

Main Results:

  • Platelets are essential mediators in the development of atherothrombosis.
  • Platelet activation drives thrombus formation and arterial occlusion.
  • Platelets significantly contribute to inflammatory processes within atherosclerotic plaques.

Conclusions:

  • Platelets play a central role in the pathophysiology of atherothrombosis.
  • Understanding platelet function is crucial for managing cardiovascular disease.
  • Antiplatelet therapies are vital for preventing atherothrombotic events.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...